全部产品 / DC2071
CAT. NO. DC2071
ABR-215062 (Laquinimod)
产品概要
Laquinimod 是一种强效免疫调节剂,可防止中枢神经系统的神经退行性变和炎症。
仅供科研使用。研究结果取决于实验条件,不构成产品性能保证。
产品身份与规格
| 目录号 | DC2071 |
|---|---|
| 产品名称 | ABR-215062 (Laquinimod) |
| CAS | 248281-84-7 |
| 分子式 | C19H17ClN2O3 |
| 分子量 | 356.8029 |
| 纯度 | 99% |
| SMILES | ClC1=C([H])C([H])=C([H])C2=C1C(=C(C(N(C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])C([H])([H])[H])=O)C(N2C([H])([H])[H])=O)O[H] |
来源列示的产品规格;具体要求以批次 COA 为准。
原始研究与产品文件
详细实验条件、性能数据和参考文献请参见英文原始资料。COA、SDS及批次文件请向客服索取。
英文原始产品资料原文参考文献
[1]. Schulze-Topphoff, Ulf., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One (2012), 7(3), e33797. [2]. Toubi E, et al. Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis. J Neuroimmunol. 2012 Oct 15;251(1-2):45-54. [3]. Brück W, et al. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol. 2012 Sep;124(3):411-24.
